Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, et al. The epidemiology of glioma in adults: a state of the science review. Neuro Oncol. 2014;16:896–913.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2013–2017. Neuro Oncol. 2020;22:iv1–96.

Article  PubMed  PubMed Central  Google Scholar 

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, et al. The 2021 WHO classification of tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23:1231–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kotecha R, Odia Y, Khosla AA, Ahluwalia MS. Key clinical principles in the management of Glioblastoma. JCO Oncol Pract. 2023;19:180–9.

Article  PubMed  Google Scholar 

Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G, Bendszus M, Balana C, Chinot O, Dirven L, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Reviews Clin Oncol. 2021;18:170–86.

Article  Google Scholar 

van Solinge TS, Nieland L, Chiocca EA, Broekman MLD. Advances in local therapy for Glioblastoma - taking the fight to the tumour. Nat Rev Neurol. 2022;18:221–36.

Article  PubMed  PubMed Central  Google Scholar 

Quail DF, Joyce JA. The Microenvironmental Landscape of Brain tumors. Cancer Cell. 2017;31:326–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Y, Ma J, Yang X, Nan F, Zhang T, Ji S, Rao D, Feng H, Gao K, Gu X, et al. Neutrophil profiling illuminates anti-tumor antigen-presenting potency. Cell. 2024;187:1422–e14391424.

Article  CAS  PubMed  Google Scholar 

Klemm F, Maas RR, Bowman RL, Kornete M, Soukup K, Nassiri S, Brouland JP, Iacobuzio-Donahue CA, Brennan C, Tabar V, et al. Interrogation of the Microenvironmental Landscape in Brain Tumors reveals Disease-specific alterations of Immune cells. Cell. 2020;181:1643–.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Friedmann-Morvinski D, Hambardzumyan D. Monocyte-neutrophil entanglement in glioblastoma. J Clin Invest 2023, 133.

Giese MA, Hind LE, Huttenlocher A. Neutrophil plasticity in the tumor microenvironment. Blood. 2019;133:2159–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Massara M, Persico P, Bonavita O, Mollica Poeta V, Locati M, Simonelli M, Bonecchi R. Neutrophils in Gliomas. Front Immunol. 2017;8:1349.

Article  PubMed  PubMed Central  Google Scholar 

Masucci MT, Minopoli M, Carriero MV. Tumor Associated neutrophils. Their role in Tumorigenesis, Metastasis, Prognosis and Therapy. Front Oncol. 2019;9:1146.

Article  PubMed  PubMed Central  Google Scholar 

Fridlender ZG, Albelda SM. Tumor-associated neutrophils: friend or foe? Carcinogenesis 2012, 33:949–55.

Gregory AD, Houghton AM. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 2011;71:2411–6.

Article  CAS  PubMed  Google Scholar 

Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more. Nat Rev Cancer. 2016;16:431–46.

Article  CAS  PubMed  Google Scholar 

Amankulor NM, Kim Y, Arora S, Kargl J, Szulzewsky F, Hanke M, Margineantu DH, Rao A, Bolouri H, Delrow J, et al. Mutant IDH1 regulates the tumor-associated immune system in gliomas. Genes Dev. 2017;31:774–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Palma M, Biziato D, Petrova TV. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer. 2017;17:457–74.

Article  PubMed  Google Scholar 

Bui TM, Yalom LK, Sumagin R. Tumor-associated neutrophils: orchestrating cancer pathobiology and therapeutic resistance. Expert Opin Ther Targets. 2021;25:573–83.

Article  CAS  PubMed  Google Scholar 

Lad BM, Beniwal AS, Jain S, Shukla P, Jung J, Shah SS, Yagnik G, Babikir H, Nguyen AT, Gill S et al. Glioblastoma induces the recruitment and differentiation of hybrid neutrophils from skull bone marrow. bioRxiv 2023.

Singhal S, Bhojnagarwala PS, O’Brien S, Moon EK, Garfall AL, Rao AS, Quatromoni JG, Stephen TL, Litzky L, Deshpande C, et al. Origin and role of a subset of Tumor-Associated neutrophils with Antigen-presenting cell features in early-stage human lung Cancer. Cancer Cell. 2016;30:120–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13:159–75.

Article  CAS  PubMed  Google Scholar 

Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the Immune System and diseases. Int J Mol Sci 2022, 23.

Gomes Dos Santos A, de Carvalho RF, de Morais ANLR, Silva TM, Baylão VMR, Azevedo M, de Oliveira AJM. Role of neutrophil-lymphocyte ratio as a predictive factor of glioma t umor grade: A systematic review. Critical reviews in oncology/hematology 2021, 163:103372.

Stadtmann A, Zarbock A. CXCR2: from bench to Bedside. Front Immunol. 2012;3:263.

Article  PubMed  PubMed Central  Google Scholar 

Wang G, Wang J, Niu C, Zhao Y, Wu P. Neutrophils: new critical regulators of Glioma. Front Immunol. 2022;13:927233.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang L, Liu Z, Wu R, Yao Q, Gu Z, Liu M. Correlation of C-X-C chemokine receptor 2 upregulation with poor prognosis and recurrence in human glioma. Onco Targets Ther. 2015;8:3203–9.

CAS  PubMed  PubMed Central  Google Scholar 

Chen N, Alieva M, van der Most T, Klazen JAZ, Vollmann-Zwerenz A, Hau P, Vrisekoop N. Neutrophils promote Glioblastoma Tumor Cell Migration after Biopsy. Cells 2022, 11.

Köhler A, De Filippo K, Hasenberg M, van den Brandt C, Nye E, Hosking MP, Lane TE, Männ L, Ransohoff RM, Hauser AE, et al. G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands. Blood. 2011;117:4349–57.

Article  PubMed  PubMed Central  Google Scholar 

Kasahara T, Mukaida N, Yamashita K, Yagisawa H, Akahoshi T, Matsushima K. IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. Immunology. 1991;74:60–7.

CAS  PubMed  PubMed Central  Google Scholar 

Griffin BD, Moynagh PN. Persistent interleukin-1beta signaling causes long term activation of NFkappaB in a promoter-specific manner in human glial cells. J Biol Chem. 2006;281:10316–26.

Article  CAS  PubMed  Google Scholar 

Tarassishin L, Lim J, Weatherly DB, Angeletti RH, Lee SC. Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression. J Proteom. 2014;99:152–68.

Article  CAS  Google Scholar 

Hor WS, Huang WL, Lin YS, Yang BC. Cross-talk between tumor cells and neutrophils through the Fas (APO-1, CD95)/FasL system: human glioma cells enhance cell viability and stimulate cytokine production in neutrophils. J Leukoc Biol. 2003;73:363–8.

Article  CAS  PubMed  Google Scholar 

Zha C, Meng X, Li L, Mi S, Qian D, Li Z, Wu P, Hu S, Zhao S, Cai J, Liu Y. Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis. Cancer Biol Med. 2020;17:154–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Powell D, Lou M, Barros Becker F, Huttenlocher A. Cxcr1 mediates recruitment of neutrophils and supports proliferation of tumor-initiating astrocytes in vivo. Sci Rep. 2018;8:13285.

Article